AJP - Heart and Circulatory Physiology, Vol 269, Issue 6 2065-H2073, Copyright © 1995 by American Physiological Society

ARTICLES

Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation

L. J. Dell'Italia, Q. C. Meng, E. Balcells, I. M. Straeter-Knowlen, G. H. Hankes, R. Dillon, R. E. Cartee, R. Orr, S. P. Bishop, S. Oparil and al. et
Birmingham Veteran Affairs Medical Center, Alabama, USA.

The current study was designed to test the hypothesis that intracardiac angiotensin-converting enzyme (ACE) activity, chymase-like activity, and angiotensin (ANG) peptide levels are increased and are positively related to wall stress estimates in response to the chronic low pressure volume overload of mitral regurgitation produced by percutaneous chordal rupture in the dog. Chronic mitral regurgitation (MR) resulted in an increase in left ventricular (LV) end-diastolic volume [59 +/- 11 (SD) to 103 +/- 32 ml, P < 0.001], LV mass (96 +/- 17 to 114 +/- 23 g, P < 0.001), and a decrease in the LV mass-to-end-diastolic volume ratio (1.64 +/- 0.22 to 1.16 +/- 0.23 g/ml, P < 0.001) measured by magnetic resonance imaging. In vitro studies of heart tissue extracts demonstrated that the majority of ANG II-forming activity was from chymase-like activity rather than from ACE activity in five normal (83.5 +/- 7.5 vs. 6.04 +/- 5.2%) and seven MR hearts (86 +/- 3.9 vs. 2.6 +/- 1.7%). ACE activity (1.22 +/- 0.22 vs. 3.55 +/- 0.62 mU/g, P < 0.05) and chymase-like activity (9.42 +/- 4.64 vs. 20.60 +/- 8.41 nmol.g-1.min-1, P < 0.05) were increased in MR compared with normal hearts. ACE activity correlated with the LV mass-to-volume ratio (r = -0.93, P < 0.001) and LV diastolic wall stress ( r = 0.71, P < 0.05); however, chymase-like activity did not correlate with any hemodynamic parameter. ANG II levels were significantly higher in the midwall of the left ventricle in MR hearts than in normal controls (85 +/- 39 vs. 27 +/- 16 pg/g, P < 0.01). Our results demonstrate a positive correlation between LV diastolic wall stress and increased ACE activity with increased ANG II stores, suggesting that mechanical wall stress activated intracardiac ACE. Although chymase accounted for most ANG II formation in vitro in extracts of both normal and MR dog hearts, the significance of this enzyme in vivo remains unclear.

This article has been cited by other articles:

				C.-C. Wei, P. A. Lucchesi, J. Tallaj, W. E. Bradley, P. C. Powell, and L. J. Dell'Italia Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H784 - H792. [Abstract] [Full Text] [PDF]

				C.-C. Wei, B. Tian, G. Perry, Q. C. Meng, Y.-F. Chen, S. Oparil, and L. J. Dell'Italia Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2254 - H2258. [Abstract] [Full Text] [PDF]

				G. J. Perry, T. Mori, C.-C. Wei, X. Y. Xu, Y.-F. Chen, S. Oparil, P. Lucchesi, and L. J. Dell'Italia Genetic Variation in Angiotensin-Converting Enzyme Does Not Prevent Development of Cardiac Hypertrophy or Upregulation of Angiotensin II in Response to Aortocaval Fistula Circulation, February 20, 2001; 103(7): 1012 - 1016. [Abstract] [Full Text] [PDF]

				L. Barlucchi, A. Leri, D. E. Dostal, F. Fiordaliso, H. Tada, T. H. Hintze, J. Kajstura, B. Nadal-Ginard, and P. Anversa Canine Ventricular Myocytes Possess a Renin-Angiotensin System That Is Upregulated With Heart Failure Circ. Res., February 16, 2001; 88(3): 298 - 304. [Abstract] [Full Text] [PDF]

				K. Kushiku, H. Yamada, K. Shibata, R. Tokunaga, T. Katsuragi, and T. Furukawa Upregulation of Immunoreactive Angiotensin II Release and Angiotensinogen mRNA Expression by High-Frequency Preganglionic Stimulation at the Canine Cardiac Sympathetic Ganglia Circ. Res., January 19, 2001; 88(1): 110 - 116. [Abstract] [Full Text] [PDF]

				F. G. Spinale, M. L. Coker, L. J. Heung, B. R. Bond, H. R. Gunasinghe, T. Etoh, A. T. Goldberg, J. L. Zellner, and A. J. Crumbley A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart Failure Circulation, October 17, 2000; 102(16): 1944 - 1949. [Abstract] [Full Text] [PDF]

				Y. Nagatomo, B. A. Carabello, M. L. Coker, P. J. McDermott, S. Nemoto, M. Hamawaki, and F. G. Spinale Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H151 - H161. [Abstract] [Full Text] [PDF]

				I. M. Straeter-Knowlen, L. J. Dell'italia, J. Dai, G. H. Hankes, A. R. Dillon, R. E. Cartee, G. M. Pohost, and D. D. Ku ACE inhibitors in HF restore canine pulmonary endothelial function and ANG II vasoconstriction Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1924 - H1930. [Abstract] [Full Text] [PDF]

				D. E. Dostal and K. M. Baker The Cardiac Renin-Angiotensin System : Conceptual, or a Regulator of Cardiac Function? Circ. Res., October 1, 1999; 85(7): 643 - 650. [Abstract] [Full Text] [PDF]

				H. Kawai, T.-H. M. Fan, E. Dong, R. A. Siddiqui, A. Yatani, S. Y. Stevens, and C.-S. Liang ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1609 - H1617. [Abstract] [Full Text] [PDF]

				M. Tanimura, V. G. Sharov, H. Shimoyama, T. Mishima, T. B. Levine, S. Goldstein, and H. N. Sabbah Effects of AT1-receptor blockade on progression of left ventricular dysfunction in dogs with heart failure Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1385 - H1392. [Abstract] [Full Text] [PDF]

				M. Koide, B. A. Carabello, C. C. Conrad, J. M. Buckley, G. DeFreyte, M. Barnes, R. J. Tomanek, C.-C. Wei, L. J. Dell'Italia, G. Cooper IV, et al. Hypertrophic response to hemodynamic overload: role of load vs. renin-angiotensin system activation Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H350 - H358. [Abstract] [Full Text] [PDF]

				M. Akasu, H. Urata, A. Kinoshita, M. Sasaguri, M. Ideishi, and K. Arakawa Differences in Tissue Angiotensin II–Forming Pathways by Species and Organs In Vitro Hypertension, September 1, 1998; 32(3): 514 - 520. [Abstract] [Full Text] [PDF]

				C. V. Thomas, M. L. Coker, J. L. Zellner, J. R. Handy, A. J. Crumbley III, and F. G. Spinale Increased Matrix Metalloproteinase Activity and Selective Upregulation in LV Myocardium From Patients With End-Stage Dilated Cardiomyopathy Circulation, May 5, 1998; 97(17): 1708 - 1715. [Abstract] [Full Text] [PDF]

				E. Balcells, Q. C. Meng, W. H. Johnson Jr., S. Oparil, and L. J. Dell'Italia Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1769 - H1774. [Abstract] [Full Text] [PDF]